BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mathijssen NC, Masereeuw R, Holme PA, van Kraaij MG, Laros-van Gorkom BA, Peyvandi F, van Heerde WL. Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect. Thrombosis Research 2013;132:256-62. [DOI: 10.1016/j.thromres.2013.05.027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Gorkom BL, Holme PA, Joch C, Rogosch T, Feussner A, McKeand W, Roberts J, van Heerde W. Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency. Hematology 2020;25:17-25. [PMID: 31852380 DOI: 10.1080/16078454.2019.1700329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hansen CE, Myers DR, Baldwin WH, Sakurai Y, Meeks SL, Lyon LA, Lam WA. Platelet-Microcapsule Hybrids Leverage Contractile Force for Targeted Delivery of Hemostatic Agents. ACS Nano 2017;11:5579-89. [PMID: 28541681 DOI: 10.1021/acsnano.7b00929] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
3 Di Minno G. Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders. Blood Rev 2015;29 Suppl 1:S26-33. [PMID: 26073366 DOI: 10.1016/S0268-960X(15)30005-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Casini A, de Moerloose P. Factor concentrates for rare congenital coagulation disorders: where are we now? Expert Opinion on Orphan Drugs 2015;4:49-62. [DOI: 10.1517/21678707.2016.1108188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Morfini M, Batorova A, Mariani G, Auerswald G, Bernardi F, Di Minno G, Dolce A, Fede C, Giansily-Blaizot M, Ingerslev J, Martinowitz U, Napolitano M, Pinotti M, Schved JF; International FVII [IF7] and Seven Treatment Evaluation Registry [STER] Study Groups. Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect. Thromb Haemost 2014;112:424-5. [PMID: 24763923 DOI: 10.1160/TH13-12-1045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Vestergaard B, Appa RS, Lykkesfeldt J, Agersø H. The kidneys play an important role in the clearance of rFVIIa in rats. Thromb Res 2014;133:1124-9. [PMID: 24731563 DOI: 10.1016/j.thromres.2014.03.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Mumford AD, Ackroyd S, Alikhan R, Bowles L, Chowdary P, Grainger J, Mainwaring J, Mathias M, O'Connell N;  BCSH Committee. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2014;167:304-326. [PMID: 25100430 DOI: 10.1111/bjh.13058] [Cited by in Crossref: 161] [Cited by in F6Publishing: 122] [Article Influence: 20.1] [Reference Citation Analysis]
8 Zhang YH, Chu C, Wang S, Chen L, Lu J, Kong X, Huang T, Li H, Cai YD. The Use of Gene Ontology Term and KEGG Pathway Enrichment for Analysis of Drug Half-Life. PLoS One 2016;11:e0165496. [PMID: 27780226 DOI: 10.1371/journal.pone.0165496] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
9 Désage S, Chamouard V, Meunier S, Enjolras N, Sobas F, Négrier C, Le Quellec S. Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots. Haemophilia 2021;27:e487-90. [PMID: 33215792 DOI: 10.1111/hae.14199] [Reference Citation Analysis]
10 Böhm E, Seyfried BK, Dockal M, Graninger M, Hasslacher M, Neurath M, Konetschny C, Matthiessen P, Mitterer A, Scheiflinger F. Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells. BMC Biotechnol 2015;15:87. [PMID: 26382581 DOI: 10.1186/s12896-015-0205-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
11 Duan X, Tang M, Zhang J, Yu H, Xu R. Promising coagulation factor VIII bypassing strategies for patients with haemophilia A. Blood Coagulation & Fibrinolysis 2014;25:539-52. [DOI: 10.1097/mbc.0000000000000098] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Giuffrida G, Nicolosi D, Giuffrida A, Rapisarda C, Calafiore V, Giuffrida A, Di Raimondo F. Successful coronary artery bypass graft surgery in severe congenital factor VII deficiency: Perioperative treatment with pd-factor VII concentrate. Haemophilia 2019;25:e135-7. [PMID: 30589157 DOI: 10.1111/hae.13657] [Reference Citation Analysis]
13 Fazavana JG, Muczynski V, Proulle V, Wohner N, Christophe OD, Lenting PJ, Denis CV. LDL receptor-related protein 1 contributes to the clearance of the activated factor VII-antithrombin complex. J Thromb Haemost 2016;14:2458-70. [PMID: 27614059 DOI: 10.1111/jth.13502] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
14 Ghadimi K, Levy JH, Welsby IJ. Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting. Anesth Analg 2016;122:1287-300. [PMID: 26983050 DOI: 10.1213/ANE.0000000000001188] [Cited by in Crossref: 49] [Cited by in F6Publishing: 7] [Article Influence: 8.2] [Reference Citation Analysis]
15 Siboni SM, Biguzzi E, Mistretta C, Garagiola I, Peyvandi F. Long-term prophylaxis in severe factor VII deficiency. Haemophilia 2015;21:812-9. [DOI: 10.1111/hae.12702] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
16 Cattivelli K, Distefano C, Bonetti L, Testa S, Siboni SM, Plebani A, Poggiani C. Recurrent Bleedings in Newborn: A Factor VII Deficiency Case Report. Transfus Med Hemother 2018;45:104-6. [PMID: 29765293 DOI: 10.1159/000481993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Strauss E, Mazzeffi M, Williams B, Key N, Tanaka K. Perioperative management of rare coagulation factor deficiency states in cardiac surgery. British Journal of Anaesthesia 2017;119:354-68. [DOI: 10.1093/bja/aex198] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]